Ross A Abrams

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. doi request reprint Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma
    Ross Allen Abrams
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612 3833, USA
    Cancer J 18:624-32. 2012
  2. doi request reprint Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful?
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, Atrium Bldg, Ground Floor, 500 S Paulina, Chicago, IL 60612, USA
    Expert Rev Gastroenterol Hepatol 6:149-61. 2012
  3. ncbi request reprint Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal"
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois 60612 3833, USA
    Drugs 67:2481-5; discussion 2491-3. 2007
  4. ncbi request reprint Radiotherapy in the adjuvant management of pancreatic adenocarcinoma
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Semin Oncol 32:S30-2. 2005
  5. ncbi request reprint Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, USA
    Surg Oncol Clin N Am 13:621-38, ix. 2004
  6. pmc The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704
    Timothy N Showalter
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Int J Radiat Oncol Biol Phys 81:1328-35. 2011
  7. pmc Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Int J Radiat Oncol Biol Phys 82:809-16. 2012
  8. doi request reprint Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients
    Benjamin T Gielda
    Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois 60612, USA
    J Thorac Oncol 6:1079-86. 2011
  9. doi request reprint Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival
    Benjamin T Gielda
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Int J Radiat Oncol Biol Phys 81:985-91. 2011
  10. doi request reprint Evaluation of four volume-based image registration algorithms
    Yunkai Zhang
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA
    Med Dosim 34:317-22. 2009

Detail Information

Publications40

  1. doi request reprint Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma
    Ross Allen Abrams
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612 3833, USA
    Cancer J 18:624-32. 2012
    ..Radiation Therapy Oncology Group trial 0848, currently accruing and ongoing, has been designed to clarify the role of radiotherapy in the adjuvant management of pancreatic cancer...
  2. doi request reprint Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful?
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, Atrium Bldg, Ground Floor, 500 S Paulina, Chicago, IL 60612, USA
    Expert Rev Gastroenterol Hepatol 6:149-61. 2012
    ..This review examines this controversy and the underlying issues and considers current efforts towards resolving them, as well as some likely future developments...
  3. ncbi request reprint Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal"
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois 60612 3833, USA
    Drugs 67:2481-5; discussion 2491-3. 2007
  4. ncbi request reprint Radiotherapy in the adjuvant management of pancreatic adenocarcinoma
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Semin Oncol 32:S30-2. 2005
    ..On balance, it is likely that optimal adjuvant therapy for pancreatic adenocarcinoma requires both radiotherapy and chemotherapy...
  5. ncbi request reprint Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, USA
    Surg Oncol Clin N Am 13:621-38, ix. 2004
    ....
  6. pmc The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704
    Timothy N Showalter
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Int J Radiat Oncol Biol Phys 81:1328-35. 2011
    ....
  7. pmc Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas
    Ross A Abrams
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Int J Radiat Oncol Biol Phys 82:809-16. 2012
    ..5FU-RT treatment was preceded and followed by randomly assigned chemotherapy, either 5-FU or gemcitabine. This analysis explored whether failure to adhere to specified RT guidelines influenced survival and/or toxicity...
  8. doi request reprint Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients
    Benjamin T Gielda
    Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois 60612, USA
    J Thorac Oncol 6:1079-86. 2011
    ..We reviewed our experience in advanced NSCLC since 1999. Subset analysis was performed on poor-risk patients...
  9. doi request reprint Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival
    Benjamin T Gielda
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Int J Radiat Oncol Biol Phys 81:985-91. 2011
    ..We reviewed a decade of single institution experience with preoperative split-course CRT followed by surgical resection to evaluate survival and identify factors that may be helpful in predicting outcome...
  10. doi request reprint Evaluation of four volume-based image registration algorithms
    Yunkai Zhang
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA
    Med Dosim 34:317-22. 2009
    ..As for the robustness, NMI and BSMI outperformed CC and LC. A guideline of image registration in our institution was given, and final visual assessment is necessary to guarantee reasonable results...
  11. ncbi request reprint Management of a patient with borderline resectable pancreatic cancer. Case report and review
    Anand P Shah
    Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois 60612, USA
    Oncology (Williston Park) 22:1524-9. 2008
    ....
  12. doi request reprint Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer
    Anand P Shah
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA
    Am J Clin Oncol 33:101-6. 2010
    ..Clearly, no combination of currently available agents is sufficient to provide acceptable cure rates in pancreatic cancer and novel therapies must be found...
  13. doi request reprint Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial
    William F Regine
    Department of Radiation Oncology, University of Maryland Medical Center, Baltimore 21030, USA
    JAMA 299:1019-26. 2008
    ..Among patients with locally advanced metastatic pancreatic adenocarcinoma, gemcitabine has been shown to improve outcomes compared with fluorouracil...
  14. ncbi request reprint Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings
    Adam Dickler
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612 3804, USA
    Semin Radiat Oncol 15:235-44. 2005
    ..The challenges of clinical research are well reflected by the controversies resulting from available studies and the difficulties in successfully designing and executing future trials...
  15. doi request reprint Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy
    Jonathan B Strauss
    Rush University Medical Center, Department of Radiation Oncology, Chicago, IL, USA
    Int J Radiat Oncol Biol Phys 77:831-5. 2010
    ..However, contraction of the lumpectomy cavity over time may have implications for the volume of tissue included in the boost field...
  16. doi request reprint A simplified technique for delivering total body irradiation (TBI) with improved dose homogeneity
    Rui Yao
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Med Phys 39:2239-48. 2012
    ..The purpose of this paper is to present and discuss the authors' TBI technique, which both simplifies the treatment process and improves the treatment quality...
  17. ncbi request reprint Radiation therapy for heterotopic ossification prophylaxis afer high-risk elbow surgery
    Jonathan B Strauss
    Northwestern Memorial Hospital, Chicago, Illinois 60611, USA
    Am J Orthop (Belle Mead NJ) 40:400-5. 2011
    ..Our findings support the idea that RT, in combination with NSAID use, is safe and efficacious in preventing development of clinically significant HO in the elbow...
  18. ncbi request reprint Adjuvant therapy for pancreatic cancer: current status, future directions
    William F Regine
    Department of Radiation Oncology, University of Maryland Medical Center, Baltimore MD 21201, USA
    Semin Oncol 33:S10-3. 2006
    ..Just cause for optimism exists, but much work remains to be done. New adjuvant therapies need to be developed and tested, in carefully designed, well-executed, efficient clinical trials...
  19. ncbi request reprint A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy
    Adam Dickler
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Brachytherapy 6:164-8. 2007
    ..This analysis was undertaken to dosimetrically compare the results of treatment using these two methods of PBI...
  20. pmc Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches
    James C Marsh
    Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    J Oncol 2010:198208. 2010
    ..This review discusses these concepts in detail as well as providing both neuroanatomic and radiobiologic background relevant to these issues...
  21. doi request reprint Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients
    James C Marsh
    Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois, USA
    Int J Radiat Oncol Biol Phys 76:504-12. 2010
    ..This review was performed to assess the feasibility of selectively sparing the limbic system during whole-brain radiotherapy and prophylactic cranial irradiation...
  22. ncbi request reprint Application of holographic display in radiotherapy treatment planning II: a multi-institutional study
    James Ch Chu
    Rush University Medical Center, Chicago, IL, USA
    J Appl Clin Med Phys 10:2902. 2009
    ..These data indicate that continued development of this technology for clinical implementation is warranted...
  23. pmc Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51
    Thomas B Daniels
    Department of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Int J Radiat Oncol Biol Phys 81:218-24. 2011
    ..We sought to independently validate this prognostic index with a separate prospectively collected data set (Intergroup 86-72-51)...
  24. pmc Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas
    Robert J Myerson
    Department of Radiation Oncology, Washington University, St Louis, MO, USA
    Int J Radiat Oncol Biol Phys 74:824-30. 2009
    ..To develop a Radiation Therapy Oncology Group (RTOG) atlas of the elective clinical target volume (CTV) definitions to be used for planning pelvic intensity-modulated radiotherapy (IMRT) for anal and rectal cancers...
  25. pmc Assessment of pancreatic cancer care in the United States based on formally developed quality indicators
    Karl Y Bilimoria
    Cancer Programs, American College of Surgeons, 633 N St Clair St, Chicago, IL 60611, USA
    J Natl Cancer Inst 101:848-59. 2009
    ..However, valid quality indicators are not currently available for pancreatic cancer management, and a composite assessment of the quality of pancreatic cancer care in the United States has not been done...
  26. doi request reprint Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis
    Thomas Liggett
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois
    Cancer 116:1674-80. 2010
    ..In this article, the authors describe a methylation profile of cell-free plasma DNA that distinguished CP from PanCa with >90% accuracy...
  27. ncbi request reprint Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials
    Christopher G Willett
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Int J Radiat Oncol Biol Phys 56:31-7. 2003
    ..This report summarizes current and future Radiation Therapy Oncology Group clinical trials in the treatment of patients with localized pancreatic cancer...
  28. ncbi request reprint Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC)
    Atif J Khan
    Department of Radiation Oncology, Section of Medical Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Radiother Oncol 81:163-7. 2006
    ..This treatment strategy is a departure from the usual practice of palliative-only therapy for all NSCLC patients presenting with metastatic disease...
  29. ncbi request reprint A feasibility study of Dynamic Phantom scanner for quality assurance of photon beam profiles at various gantry angles
    Yunkai Zhang
    Department of Medical Physics, Rush University Medical Center, 1653 West Congress Parkway, Chicago, Illinois 60612, USA
    J Appl Clin Med Phys 6:50-61. 2005
    ..Caution should be taken when using this device to acquire basic electron dosimetry data...
  30. ncbi request reprint Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors
    Tom C Nguyen
    Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 4606, USA
    J Gastrointest Surg 7:1-9; discussion 9-11. 2003
    ..These results imply that no negative long-term QOL measures are associated with radical pancreaticoduodenectomy (as performed in this study) for periampullary adenocarcinoma...
  31. ncbi request reprint Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985?
    Ross A Abrams
    Division of Radiation Oncology, Kimmel Cancer Center, Johns Hopkins University and Johns Hopkins Hospital, Baltimore, MD 21231, USA
    Int J Radiat Oncol Biol Phys 56:3-9. 2003
    ....
  32. ncbi request reprint Pancreatic cancer
    Theresa Pluth Yeo
    Departments of Surgery, Oncology, Pathology and Medicine Johns Hopkins Medical Institutions Baltimore, Maryland, USA
    Curr Probl Cancer 26:176-275. 2002
  33. ncbi request reprint Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival
    Taylor S Riall
    Departments of Surgery, The Sol Goldman Pancreas Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Gastrointest Surg 9:1191-204; discussion 1204-6. 2005
    ..002)...
  34. ncbi request reprint A challenge to the therapeutic nihilism of ESPAC-1
    Mary C Koshy
    Int J Radiat Oncol Biol Phys 61:965-6. 2005
  35. ncbi request reprint Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study
    David S Ettinger
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231 1000, USA
    J Clin Oncol 23:4991-8. 2005
    ....
  36. ncbi request reprint Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct
    Michael A Hughes
    Therapeutic Radiologists, Inc, Kansas City, MO, USA
    Int J Radiat Oncol Biol Phys 68:178-82. 2007
    ..To examine the effect of adjuvant chemoradiation for adenocarcinoma of the distal common bile duct (DCBD) after pancreaticoduodenectomy (PD) on local control and survival...
  37. pmc Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality
    Charles J Yeo
    Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Ann Surg 236:355-66; discussion 366-8. 2002
    ..To evaluate, in a prospective, randomized single-institution trial, the end points of operative morbidity, operative mortality, and survival in patients undergoing standard versus radical (extended) pancreaticoduodenectomy...
  38. ncbi request reprint Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma
    Yvette L Kasamon
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA
    Biol Blood Marrow Transplant 11:39-46. 2005
    ..Whether allogeneic BMT ultimately confers an advantage because of a graft-versus-lymphoma effect remains to be determined...
  39. ncbi request reprint High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement
    Yvette L Kasamon
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans St, Baltimore, MD 21231, USA
    Biol Blood Marrow Transplant 11:93-100. 2005
    ..These data suggest that patients with lymphomatous involvement of the CNS who achieve CNS remission should be offered BMT if it is otherwise indicated...
  40. ncbi request reprint Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum
    Michael J Swartz
    Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD 21231, USA
    Arch Surg 142:285-8. 2007
    ..Adjuvant chemoradiation improves local control and survival in patients with node-positive duodenal adenocarcinoma treated with pancreaticoduodenectomy...